25-27
Aug
2026
6-8
Oct
2026
Changchun GeneScience Pharmaceutical Co.,Ltd.
About Changchun GeneScience Pharmaceutical Co.,Ltd.
Certifications
-
GMP
Categories
Meet us at
-
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026 -
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
-
Country/Region:China
-
Founded:1997
-
On CPHI since:2023
-
Certificates:1
-
Employees:5000+
Company types
Primary activities
Contact info
-
-
-
No. 1718 Yueda Road, Changchun, 130012, Changchun City, China, China
Products from Changchun GeneScience Pharmaceutical Co.,Ltd. (5)
-
Product Givopegsomatropin (PEG-hGH, PEG-somatropin) Injection
Commercialized in China since 2014
Administration once a week
-
Product Somatropin (hGH) Injection
Commercialized for more than 20 years -
Product PEG （ Polyethylene glycol )
We can manufacture high quality activated PEG products with high purity in cGMP grade. Our reactive polyethylene glycol derivatives and raw materials can be utilized widely in the pharmaceutical, biotechnology and emerging chemical specialty fields.
Customized PEG synthesis service is available:... -
Product Cetrorelix for Injection
For more information, please contact us at [email protected] -
Product Follitropin (FSH) Injection
12.5IU precise adjustment.
Available in three injection strengths(300/450/600IU).
Changchun GeneScience Pharmaceutical Co.,Ltd. Resources (2)
-
News Firsekibart Approved with 87% Reduction in Gout Recurrence Over 6 Months
Recently, the National Medical Products Administration (NMPA) of China announced that Gensci's Class 1 innovative drug Jin Beixin Firsekibart has received approval. This drug is indicated for gouty arthritis (GA) treatment in adult patients for whom NSAIDs and/or colchicine are contraindicated, not tolerated, or ineffective and for whom repeated courses of corticosteroids are not suitable. Leveraging its clinical advantages of sustained symptom control, rapid onset of action and a favorable safety profile, Jin Beixin Firsekibart is expected to be China’s best-selling drug to address the unmet need in the treatment of autoimmune diseases. -
Brochure Product List
GenSci's Product List